Tag:
SF-1019
Latest Headlines
Latest Headlines
SEC lays out "tall tales" in $20M biotech securities scam
According to executives at Immunosyn and its controlling shareholder Argyll Biotechnologies, the biotech was onto something truly special. Its lead drug, SF-1019, which had been derived from goat's
